Ad is loading...
Ad is loading...
ADNRX vs FSMAX
ADNRX vs FSMAX Comparison
Open Charts ADNRX vs FSMAX
American Beacon ARK Transfmt Innov R6
Price$15.43
Change+$0.39 (+2.59%)
VolumeN/A
CapitalizationN/A
Fidelity Extended Market Index
Price$95.84
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
ADNRX vs FSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. FSMAX commentary
Nov 23, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Sell and FSMAX is a Buy.
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. ADNRX (204M). FSMAX pays higher dividends than ADNRX: FSMAX (1.10) vs ADNRX (0.00). ADNRX was incepted earlier than FSMAX: ADNRX (4 years) vs FSMAX (13 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. FSMAX (18.00). ADNRX (0) and FSMAX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 38.09 vs. ADNRX (24.09).
| ADNRX | FSMAX | ADNRX / FSMAX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 13 years | - |
| Gain YTD | 4.735 | 22.777 | 21% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 204M | 40B | 1% |
| Annual Yield % from dividends | 0.00 | 1.10 | - |
| Returns for 1 year | 24.09 | 38.09 | 63% |
| Returns for 3 years | -62.84 | 7.70 | -816% |
| Returns for 5 years | N/A | 56.62 | - |
| Returns for 10 years | N/A | 85.67 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...